Home Biostage Inc.

Biostage Inc.

Biostage Awarded SBIR Fast-Track Grant to Develop Cellspan™ Esophageal Implant (CEI) as a Novel Treatment for Esophageal Atresia in Pediatric Patients

3/29/18: Potential to provide up to $1.7 million of nondilutive funds to support pre-clinical testing of Company's pediatric esophageal implant product candidate.